Literature DB >> 6375982

Mitral valve regurgitation.

R A O'Rourke, M H Crawford.   

Abstract

The mitral apparatus is a complex structure composed of several components, each of which can be affected by a variety of diseases, resulting in mitral regurgitation. The physiologic consequences of mitral regurgitation include reduced forward stroke volume; increased left atrial volume and pressure; and reduced resistance to left ventricular ejection. The latter explains why indices of systolic left ventricular function (ejection fraction) are often increased early in the course of mitral regurgitation. With the insidious development of mitral regurgitation, the left atrium dilates to accommodate the increase in volume, thereby reducing the atrial pressure. However, with the acute development of mitral regurgitation into a nondilated left atrium, pressure rises rapidly, producing pulmonary edema. The predominant clinical symptoms in chronic mitral regurgitation of dyspnea and fatigue result from pulmonary venous hypertension and low cardiac output. The cardinal physical finding is a mitral systolic murmur. Since the murmur can assume various configurations, the most reliable way to establish its correct origin is by bedside physiologic maneuvers. Typically, in the beat following a premature contraction or after a long pause during atrial fibrillation, the murmur of mitral regurgitation is unchanged in intensity, but murmurs due to left ventricular outflow obstruction increase. Also, isometric handgrip exercise increases the intensity of the murmur and a Valsalva maneuver decreases it during the strain phase. Echocardiography is the most useful noninvasive technique for evaluating patients with mitral regurgitation. Visualization of the mitral apparatus may establish the etiology of regurgitation, and measurement of left atrial size and left ventricular size and performance is useful for assessing the functional significance of the lesion. Doppler echocardiography can establish the diagnosis of mitral regurgitation in difficult cases with multi valve disease and can estimate the severity of the regurgitation. Cardiac catheterization and angiography are usually reserved for the patient being considered for valvular surgery. The natural history of chronic mitral regurgitation is characterized by slowly progressive symptoms, and often the onset of disabling symptoms is the result of irreversible left ventricular dysfunction. Medical therapy consists of digitalis, diuretics, and vasodilators for symptomatic patients. When symptoms occur despite this therapy, valvular surgery should be considered before left ventricular function becomes abnormal.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6375982     DOI: 10.1016/0146-2806(84)90021-5

Source DB:  PubMed          Journal:  Curr Probl Cardiol        ISSN: 0146-2806            Impact factor:   5.200


  4 in total

1.  Diagnosis and management of infective endocarditis.

Authors:  J S MacGregor; M D Cheitlin
Journal:  Tex Heart Inst J       Date:  1989

2.  IMPULSE: the impact of gender on the presentation and management of aortic stenosis across Europe.

Authors:  Richard Paul Steeds; David Messika-Zeitoun; Jeetendra Thambyrajah; Antonio Serra; Eberhard Schulz; Jiri Maly; Marco Aiello; Tanja K Rudolph; Guy Lloyd; Alessandro Santo Bortone; Alberto Clerici; Georg Delle-Karth; Johannes Rieber; Ciro Indolfi; Massimo Mancone; Loic Belle; Alexander Lauten; Martin Arnold; Berto J Bouma; Matthias Lutz; Cornelia Deutsch; Jana Kurucova; Martin Thoenes; Peter Bramlage; Norbert Frey
Journal:  Open Heart       Date:  2021-01

3.  An investigation of the anisotropic mechanical properties and anatomical structure of porcine atrioventricular heart valves.

Authors:  Samuel Jett; Devin Laurence; Robert Kunkel; Anju R Babu; Katherine Kramer; Ryan Baumwart; Rheal Towner; Yi Wu; Chung-Hao Lee
Journal:  J Mech Behav Biomed Mater       Date:  2018-07-18

Review 4.  Preprocedural planning of transcatheter mitral valve interventions by multidetector CT: What the radiologist needs to know.

Authors:  Lorenzo Faggioni; Michela Gabelloni; Sandra Accogli; Marco Angelillis; Giulia Costa; Paolo Spontoni; Anna Sonia Petronio; Davide Caramella
Journal:  Eur J Radiol Open       Date:  2018-08-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.